Skip to main content
. Author manuscript; available in PMC: 2018 Jun 18.
Published in final edited form as: J Mol Neurosci. 2017 May 30;62(2):199–208. doi: 10.1007/s12031-017-0931-z

Fig. 1.

Fig. 1

Effects of gp120 on BV2 cell viability. BV2 cells were exposed to HIV-1 gp120 at the indicated doses for 12 h. Control cells were treated with phosphate buffer vehicle. Cell viability was analyzed by MTTassay. Error bar: standard error of the mean (***P < 0.001 versus control, n = 8, one-way ANOVA)